Načítá se...
Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at Stanford
BACKGROUND: In light of recent Food and Drug Administration (FDA) approval of immune checkpoint inhibitors for mismatch repair deficient (dMMR) malignancies, identifying patients with dMMR malignancies has become increasingly important. Although screening for dMMR in colorectal cancer (CRC) is recom...
Uloženo v:
| Vydáno v: | JNCI Cancer Spectr |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7667994/ https://ncbi.nlm.nih.gov/pubmed/33225206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkaa054 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|